Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinoma cells

Cancer Research

Volumn 59, Issue 22, 1999, Pages 5822-5829

  Xu, Lei ^a   Xie, Keping ^a   Mukaida, Naofumi ^b   Matsushima, Kouji ^b   Fidler, Isaiah J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MESSENGER RNA; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; OVARY CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION;

BINDING, COMPETITIVE; CELL HYPOXIA; FEMALE; GENES, REPORTER; HALF-LIFE; HUMANS; INTERLEUKIN-8; LUCIFERASES; NEOPLASM PROTEINS; NF-KAPPA B; OVARIAN NEOPLASMS; OXYGEN; RNA, MESSENGER; TIME FACTORS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0033571167     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Heintz, A. Surgery in advanced ovarian carcinoma: is there proof to show the benefit? Eur. J. Surg. Oncol., 14: 91-99, 1988.
2. Folkman, J. Angiogenesis in cancer vascular, rheumatoid and other diseases. Nat. Med., 1: 27-31, 1985.
3. Samoszuk, M., Lin, F., Rim, P., and Stratheam, G. New marker for blood vessels in human ovarian and endometrial cancers. Clin. Cancer Res., 2: 1867-1871, 1996.
4. Folkman, J., and Klagsbrun, M. Angiogenic factors. Science (Washington DC), 235: 442-447, 1987.
5. Fidler, I. J., and Ellis, L. M. The implications of angiogenesis of the biology and therapy of cancer metastasis. Cell, 79: 185-188, 1994.
6. Yoneda, J., Kuniyasu, H., Crispen, M. A., Price, J. E., Bucana, C. D., and Fidler, I. J. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice. J. Natl. Cancer Inst., 90: 447-454, 1998.
7. Matsushima, K., and Oppenheim, J. Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL-8 and TNF. Cytokine, 1: 2-12, 1989.
8. Arenberg, D. A., Kunkel, S. L., Polverini, P. J., Class, M., Burdick, M. D., and Strieter, R. M. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J. Clin. Invest, 97: 2792-2802, 1996.
9. Strieter, R. M. Interleukin-8 as a macrophage derived mediator of angiogenesis. Science (Washington DC), 258: 1798-1801, 1992.
10. Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiDietro, L. A., Elner, V. M., Elner, S. G., and Strieter, R. M. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science (Washington DC), 258: 1798-1801, 1992.
11. Luca, M., Huang, S., Gershenwald, J. E., Singh, R. K., Reich, R., and Bar-Eli, M. Expression of interleukin-8 by human melanoma cells upregulates MMP-2 activity and increases tumor growth and metastasis. Am. J. Pathol., 151: 41-49, 1997.
12. Singh, R. K., Gutman, M., Radinsky, R., Corazon, C. D., and Fidler, I. J. Expression of interleukin-8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res., 54: 3242-3247, 1994.
13. Greene, G. F., Kitadai, Y., Pettaway, C. A., von Eschenbach, A. C., Bucana, C. D., and Fidler, I. J. Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique. Am. J. Pathol., 150: 1571-1582, 1997.
14. Kitadai, Y., Haruma, K., Sumii, K., Yamamoto, S., Ue, T., Yokozaki, H., Yasui, W., Ohmoto, Y., Kajiyama, G., Fidler, I. J., and Tahara, E. Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am. J. Pathol., 152: 93-100, 1998.
15. Vaupel, P. W. Blood flow, oxygen, nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res., 49: 6449-6465, 1989.
16. Sutherland, R. M. Tumor hypoxia and gene expression. Acta Oncol., 37: 57-574, 1998.
17. Brown, J. M., and Giaccia, A. J. Tumor hypoxia: the picture has changed in the 1990s. Int. J. Radiat. Biol., 65: 95-102, 1994.
18. Dachs, G. U., and Stratford, I. J. The molecular response of mammalian cells to hypoxia and the potential for exploitation in cancer therapy. Br. J. Cancer, 74 (Suppl.): s126-s132, 1996.
19. Jang, A., and Hill, R. P. An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastasis-associated genes in murine tumor cells. Clin. Exp. Metastasis, 15: 468-483, 1997.
20. Brizel, D. M., Scully, S. P., Harrelson, J. M., Layfield, L. J., Bean, J. M., Prosnitz, L. R., and Dewhirst, M. W. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res., 56: 941-943, 1996.
21. Hockel, M., Schlenger, K., Aral, B., Mitze, M., Schaffer, U., and Vaupel, P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res., 56: 4509-4515, 1996.
22. Schweiki, D. A., Itin, D. S., and Keshet, E. Vascular endothelial growth factor induced by hypoxia-initiated angiogenesis. Nature (Lond.), 359: 843-845, 1992.
23. Fogh, J., and Trempe, G. Human Tumor Cells In Vitro, pp. 115-159. New York: Plenum Press, 1975.
24. Yu, D., Wolf, J. K., Scanlon, M., Price, J. E., and Hung, M. C. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A. Cancer Res., 53: 891-898, 1993.
25. Buick, R. N., Pullano, R., and Trent, J. M. Comparative properties of five human ovarian adenocarcinoma cell lines. Cancer Res., 45: 3668-3676, 1985.
26. Bucana, C. D., Radinsky, R., Dong, Z., Sanchez, R., Brigati, D. J., and Fidler, I. J. A rapid colorimetric in situ mRNA hybridization technique using hyperbiotinylated oligonucleotide probes for analysis of mdr1 in mouse colon carcinoma cells. J. Histochem. Cytochem., 41: 499-506, 1993.
27. Lindholm, D., Henmann, R., Hengerer, B., and Thoenen, H. Interleukin-1 increases stability and transcription of mRNA encoding nerve growth factor in cultured rat fibroblasts. J. Biol. Chem., 263: 16348-16351, 1988.
28. Desbaillets, I., Disensns, A. C., Tribolet, N., Hamon, M. F., and Van Meir, E. G. Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma. Oncogene, 18: 1447-1455, 1999.
29. Mukaida, N., Mahe, Y., and Matsushima, K. Cooperative interaction of nuclear factor-κB and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by proinflammatory cytokines. J. Biol. Chem., 265: 21128-21133, 1990.
30. Mahe, Y., Mukaida, N., Kuno, K., Akiyama, M., Ikeda, N., Matsushima, K., and Murakami, S. Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on NF-κB and CCAAT/enhancer-binding protein-like cis-elements. J. Biol. Chem., 266: 13759-13763, 1991.
31. Yasumoto, K., Okamoto, S., Mukaida, N., Murakami, S., Mai, M., and Matsushima, K. Tumor necrosis factor α and interferon γ synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-κB-like binding sites of the interleukin 8 gene. J. Biol. Chem., 267: 22506-22511, 1992.
32. Arici, A., Oral, E., Bukulmez, O., Buradagunta, S., Engin, O., and Olive, D. Interleukin-8 expression and modulation in human preovulatory follicles and ovarian cells. Endocrinology, 137: 3762-3769, 1996.
33. Gawrychowski, K., Skopinska-Rozewska, E., Barcz, E., Sommer, E., Szaniawska, B., Roszkowska-Purska, K., Janik, P., and Zielinski, J. Angiogenic activity of interleukin-8 content of human ovarian cancer ascites. Eur. J. Gynaec. Oncol., 19: 262-264, 1997.
34. Watson, J. M., Kinston, D. G. I., Chordia, M. D., Chandhary, A. G., Rinehart, C. A., and Haskill, J. S. Identification of the structural region of Taxol that may be responsible for cytokine gene induction and cytotoxicity in human ovarian cancer cells. Cancer Chemother. Pharmacol., 41: 391-397, 1998.
35. Haskill, J. S., Becker, S., Flower, W., and Walton, L. Mononuclear-cell infiltration in ovarian cancer: inflammatory cell infiltrates from tumor and ascites material. Br. J. Cancer, 45: 728-736, 1982.
36. Karokurum, M., Shreeniwas, R., Chen, J., and Stern, D. Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J. Clin. Invest., 93: 1564-1570, 1994.
37. Metinko, A. P., Kunkel, S. L., Standiford, T. J., and Strieter, R. M. Anoxia-hyperoxia induces monocyte-derived interleukin-8. J. Clin. Invest., 90: 791-798, 1992.
38. Matsushima, K., Baldwin, E. T., and Mukaida, N. Interleukin-8 and MCAF: novel leukocyte recruitment and activating cytokines. Chem. Immunol. 51: 236-265, 1992.
39. Levy, A. P., Levy, N. S., Wegner, S., and Goldberg, M. A. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem., 270: 13333-13340, 1995.
40. Levy, A. P., Levy, N. S., and Goldberg, M. A. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J. Biol. Chem., 277: 2746-2753, 1996.
41. Damert, A., Machein, M., Breier, G., Jujita, M. Q., Hanahan, D., Risau, W., and Plate, K. H. Up-Regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms. Cancer Res., 57: 3860-3864, 1997.
42. Mukaida, N., Morita, M., Ishikawa, Y., Rice, N., Okamoto, S-I., Kasahara, T., and Matsushima, K. Novel mechanism of glucocorticoid-mediated gene expression. J. Biol. Chem., 269: 13289-13295, 1994.
43. Maxwell, P. H., Pugh, C. W., and Ratcliffe, P. J. Inducible operation of the erythropoietin 3' enhancer in multiple cell lines: evidence for a widespread oxygen-sensing mechanism. Proc. Natl. Acad. Sci. USA, 90: 2423-2427, 1993.
44. Bandyopadhyay, R. S., Phelan, M., and Faller, D. V. Hypoxia induces AP-1-regulated genes and AP-1 transcription factor binding in human endothelial and other cell types. Biochem. Biophys., 1264: 72-78, 1995.
45. Yao, K. S., Xanthoudakis, S., Curran, T., and O'Dwyer, P. J. Involvement of NF-κB in the induction of NAK(P)H quinone oxidoreductase (DT-diaphorase) by hypoxia, oltipraz and mitomycin C. Biochem. Pharmacol., 49: 275-282, 1995.
46. Smeal, T., Angel, P., Meek, J., and Karin, M. Different requirements for formation of Jun:Jun and Jun:Fos complexes. Genes Dev., 3: 2091-2100, 1989.
47. Laderoute, K. R., Calaoagan, J. M., Mendonca, H. L., Ausserer, W. A., Chen, E. Y., Giaccia, A. J., Maxwell, P. H., Pugh, C. W., and Ratcliffe, P. J. Early responses of SiHa human squamous carcinoma cells to hypoxic signals: evidence of parallel activation of NF-κB and AP-1 transcriptional complexes. Int. J. Oncol., 8: 875-882, 1996.
48. Rupec, R. A., and Baeuerle, P. A. The genomic response of tumor cells to hypoxia and reoxygenation: differential activation of transcription factors AP-1 and NF-κB. Eur. J. Biochem., 234: 632-640, 1995.
49. Schmedtje, J. F., Liu, W. L., Ji, Y. S., Thompson, T. M., and Runge, M. S. Evidence of hypoxia-inducible factor-1 in vascular endothelial and smooth muscle cells. Biochem. Biophys. Res. Commun., 220: 687-691, 1996.
50. Semenza, G. L., Nefelt, M. K., and Chi, S. M. Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene. Proc. Natl. Acad. Sci. USA, 88: 5680-5684, 1991.
51. Semenza, G. L., and Wang, G. L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol., 12: 5447-5454, 1992.
52. Kvietikova, I., Wenger, R. H., Marti, H. H., and Gassmann, M. The transcription factors ATF-1 and CREB-1 bind constitutively to the hypoxia-inducible factor-1 (HIF-1) DNA recognition site. Nucleic Acids Res., 23: 4542-4550, 1995.
53. arj, a novel p300/CbP binding protein, during transactivation by HIF-1. Genes Devel., 13: 64-75, 1999.
54. Claffey, K. P., Shih, S. C., Mullen, A., Dziennis, S., Cusick, J. L., Abrams, K. R., Lee, S. W., and Detmar, M. Identification of a human VEGF/VPF 3' untranslated region mediating hypoxia-induced mRNA stability. Mol. Biol. Cell, 9: 469-481, 1998.
55. Shih, S. C., and Claffey, K. P. Regulation of human vascular endothelial growth factor mRNA stability in hypoxia by heterogeneous nuclear ribonucleoprotein L. J. Biol. Chem., 74: 1359-1365, 1999.